Salivary Secretory Immunoglobulin (SIgA) and Lysozyme in Malignant Tumor Patients

Table 3

The concentration of salivary SIgA and lysozyme in various cancer patients.

	Pulmonary cancer ()	Digestive tract malignant tumor ()	Hematopoietic system tumor ()
SIgA (µg/mL)	28.47 ± 2.69	26.87 ± 3.88	21.41 ± 1.63
Lysozyme (ng/mL)	53.38 ± 14.74	52.39 ± 12.64	56.13 ± 7.61

For SIgA, the differences of SIgA concentration between any two patient groups were significant (). For lysozyme, there was significant difference between hematopoietic system tumor and digestive tract malignant tumor groups; the other groups showed no significant difference.